Annonaceous Acetogenins Synergistically Inhibit Hepatocellular Carcinoma with Sorafenib.
Li RS, Li LY, Zhu XF, Li X, Wang CY, Qiu SJ, Zhou J, Fan J, Hu B, Mu Q.
Li RS, et al. Among authors: wang cy.
J Nat Prod. 2024 Jan 26;87(1):14-27. doi: 10.1021/acs.jnatprod.3c00667. Epub 2024 Jan 17.
J Nat Prod. 2024.
PMID: 38233978
Despite providing an advantage in terms of patient survival, sorafenib has shown poor clinical efficacy and severe side effects after long-term treatment. Thus, combination treatment is a potential way to increase the effectiveness and reduce the dose-limiting toxicity of …
Despite providing an advantage in terms of patient survival, sorafenib has shown poor clinical efficacy and severe side effects after long- …